BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8541238)

  • 1. A sensitive assay for measurement of plasma estrone sulphate in patients on treatment with aromatase inhibitors.
    Lønning PE; Ekse D
    J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):409-12. PubMed ID: 8541238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An optimised, highly sensitive radioimmunoassay for the simultaneous measurement of estrone, estradiol and estrone sulfate in the ultra-low range in human plasma samples.
    Geisler J; Ekse D; Helle H; Duong NK; Lønning PE
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):90-5. PubMed ID: 18242079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma estrogen suppression with aromatase inhibitors evaluated by a novel, sensitive assay for estrone sulphate.
    Lønning PE; Geisler J; Johannessen DC; Ekse D
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):255-60. PubMed ID: 9365198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dexaminoglutethimide, an optical isomer of aminoglutethimide, on the disposition of estrone sulfate in postmenopausal breast cancer patients.
    Geisler J; Lundgren S; Berntsen H; Greaves JL; Lønning PE
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2687-93. PubMed ID: 9709932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of aminoglutethimide on plasma levels of estrone sulphate and dehydroepiandrosterone sulphate in postmenopausal breast cancer patients.
    Geisler J; Lien EA; Ekse D; Lønning PE
    J Steroid Biochem Mol Biol; 1997; 63(1-3):53-8. PubMed ID: 9449206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators.
    Geisler J
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):245-53. PubMed ID: 14623518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LC-MS/MS coupled with immunoaffinity extraction for determination of estrone, 17beta-estradiol and estrone 3-sulfate in human plasma.
    Hosogi J; Tanaka H; Fujita K; Kuwabara T; Ikegawa S; Kobayashi N; Mano N; Goto J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(2):222-7. PubMed ID: 19700374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel HPLC-RIA method for the simultaneous detection of estrone, estradiol and estrone sulphate levels in breast cancer tissue.
    Geisler J; Berntsen H; Lonning PE
    J Steroid Biochem Mol Biol; 2000 Apr; 72(5):259-64. PubMed ID: 10822015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients.
    Pasqualini JR; Chetrite G; Blacker C; Feinstein MC; Delalonde L; Talbi M; Maloche C
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1460-4. PubMed ID: 8636351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment with 4-hydroxyandrostenedione and aminoglutethimide: effects on aromatase inhibition and oestrogen suppression.
    MacNeill FA; Jacobs S; Lønning PE; Powles TJ; Dowsett M
    Br J Cancer; 1994 Jun; 69(6):1171-5. PubMed ID: 8198987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
    Santen RJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer.
    Robarge JD; Desta Z; Nguyen AT; Li L; Hertz D; Rae JM; Hayes DF; Storniolo AM; Stearns V; Flockhart DA; Skaar TC; Henry NL
    Breast Cancer Res Treat; 2017 Feb; 161(3):453-461. PubMed ID: 27943008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of aromatase inhibitors on plasma total homocysteine in postmenopausal breast cancer patients.
    Anker GB; Refsum H; Ueland PM; Johannessen DC; Lien EA; Lonning PE
    Clin Chem; 1999 Feb; 45(2):252-6. PubMed ID: 9931048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific radioimmunoassay of estrone sulfate. Application to measurement in male plasma.
    Giton F; Valleix A; Boudou P; Villette JM; Bélanger A; Galons H; Fiet J
    J Steroid Biochem Mol Biol; 2002 May; 81(1):85-94. PubMed ID: 12127046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
    Miller WR; Stuart M; Sahmoud T; Dixon JM
    Br J Cancer; 2002 Oct; 87(9):950-5. PubMed ID: 12434282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aromatase inhibitors].
    Feutrie ML; Bonneterre J
    Bull Cancer; 1999 Oct; 86(10):821-7. PubMed ID: 10572233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy.
    Bellet M; Gray KP; Francis PA; Láng I; Ciruelos E; Lluch A; Climent MA; Catalán G; Avella A; Bohn U; González-Martin A; Ferrer R; Catalán R; Azaro A; Rajasekaran A; Morales J; Vázquez J; Fleming GF; Price KN; Regan MM
    J Clin Oncol; 2016 May; 34(14):1584-93. PubMed ID: 26729437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between aromatase inhibitors and sequential use.
    Lønning PE
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):275-82. PubMed ID: 14623521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with formestane alone and in combination with aminoglutethimide in heavily pretreated breast cancer patients: clinical and endocrine effects.
    Geisler J; Johannessen DC; Anker G; Lønning PE
    Eur J Cancer; 1996 May; 32A(5):789-92. PubMed ID: 9081355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a rapid and ultrasensitive RIA method for estrogen (E2, E1, E1-S) determination with selective solid phase extraction.
    Martinetti A; Seregni E; Bajetta E; Bolelli GF; Ferrari L; Massaron S; Botti C; Bombardieri E
    Int J Biol Markers; 1997; 12(3):102-5. PubMed ID: 9479591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.